EUVIMEDEUVIMED entdecken
Crossref

Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice

Qian Lu, Ninglin Xia, Jicheng Wang, Yulin Yi, Xue Fan, Ming Jin, Xiaofei Huang, Wenwen Xin, Li Sun, Jinyu Hu, Zhenzhou Jiang, Qinwei Yu

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Qian Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009…. Hauptthemen laut MEDLINE: Fenofibrate, Tretinoin, Retinoic Acid Receptor alpha, Hyperlipidemias. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Natural Science Foundation, Graduate Research and Innovation Projects of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

All-trans retinoic acid (ATRA), the active metabolite of vitamin A, serves as the first-line therapy for acute promyelocytic leukemia (APL) in clinical. However, increasing clinical evidence indicates that ATRA treatment is frequently associated with dyslipidemia, the underlying molecular mechanisms of which remain unclear. Fenofibrate, a specific agonist of peroxisome proliferator-activated receptor alpha (PPARα), is widely used in the management of metabolic disorders, yet its potential to alleviate ATRA-induced lipid abnormalities has not been fully elucidated. In this study, we established a mouse model of ATRA-induced hyperlipidemia and hepatic steatosis to investigate the underlying mechanisms and assess the therapeutic effects of fenofibrate as a combinatorial agent. Our findings revealed that ATRA promoted the formation of RARα/RXRα heterodimers, which activated the hepatic FOXO1-APOCIII pathway, leading to hyperlipidemia and hepatic lipid accumulation in mice. Fenofibrate effectively counteracted these effects by activating PPARα, thereby competitively inhibiting RARα binding to RXRα and restoring lipid homeostasis. This study reveals a novel mechanism underlying ATRA-induced hyperlipidemia and hepatic lipid accumulation, which offers a theoretical foundation for the clinical use of fenofibrate in managing ATRA-induced hyperlipidemia and hepatic steatosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenofibrateTretinoinRetinoic Acid Receptor alphaHyperlipidemiasFatty LiverRetinoid X Receptor alphaAnimalsMiceMalePPAR alphaMice, Inbred C57BLHumansLiverProtein Multimerization

Stichwörter der Autor:innen

All-trans retinoic acidFenofibrateHepatic steatosisHyperlipidemiaRARα/RXRα

Substanzen

FenofibrateTretinoinRetinoic Acid Receptor alphaRetinoid X Receptor alphaPPAR alphaRara protein, mouse

Autor:innen und Institutionen

  • New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
  • New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance,…
  • New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address: yuqinwei7213@cpu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Foundation
  • Graduate Research and Innovation Projects of Jiangsu Province
  • China Postdoctoral Science Foundation
  • Double First Class University Plan

Zitieren

APA

Lu, Q., Xia, N., Wang, J., Yi, Y., Fan, X., Jin, M., Huang, X., Xin, W., Sun, L., Hu, J., Jiang, Z., & Yu, Q. (2026). Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112357

Vancouver

Lu Q, Xia N, Wang J, Yi Y, Fan X, Jin M, et al. Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112357

BibTeX
@article{Lu2026,
  author = {Lu, Qian and Xia, Ninglin and Wang, Jicheng and Yi, Yulin and Fan, Xue and Jin, Ming and Huang, Xiaofei and Xin, Wenwen and Sun, Li and Hu, Jinyu and Jiang, Zhenzhou and Yu, Qinwei},
  title = {Fenofibrate anti-RARα/RXRα dimerization to attenuate all-trans retinoic acid-induced hyperlipidemia and hepatic steatosis in mice},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112357}
}
Kostenlos starten →